Granbury Hospital Corporation
Granbury Hospital Corporation was paid $4.94M by Medicaid between Nov 2020 and Nov 2024, across 45 billing codes. Its largest line is 99283, emergency room visit (moderate) — 42% of everything it billed.
GRANBURY, TX 76048
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 855 | $43K | |
| 2021 | 7,315 | $631K | |
| 2022 | 10,517 | $1.47M | |
| 2023 | 10,327 | $1.97M | |
| 2024incomplete | 4,788 | $829K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 42% | 5,939 | 5,673 | $2.07M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 28% | 2,593 | 2,446 | $1.39M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 10% | 1,759 | 1,705 | $506K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8.2% | 1,203 | 1,165 | $406K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.3% | 4,087 | 3,905 | $162K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.4% | 3,011 | 2,652 | $117K |
| 71045 | Radiologic examination, chest; single view | 1.2% | 747 | 694 | $58K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 551 | 498 | $45K |
| 80053 | Comprehensive metabolic panel | <1% | 3,212 | 2,966 | $36K |
| 86403 | <1% | 1,666 | 1,621 | $30K | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | <1% | 81 | 77 | $28K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,642 | 3,325 | $26K |
33 more codes
| 81001 | <1% | 3,328 | $17K | |
| 86756 | <1% | 245 | $8K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 40 | $5K |
| 94060 | <1% | 25 | $4K | |
| CP007 | <1% | 51 | $3K | |
| 84703 | <1% | 260 | $3K | |
| 94729 | <1% | 25 | $2K | |
| 87081 | <1% | 139 | $2K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 13 | $2K |
| 94726 | <1% | 12 | $1K | |
| J2704 | Injection, propofol, 10 mg | <1% | 68 | $1K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 13 | $839.14 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 44 | $768.25 |
| 83690 | <1% | 135 | $755.14 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 27 | $731.61 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 158 | $652.02 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 30 | $385.18 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 16 | $360.28 |
| 83655 | <1% | 13 | $264.86 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 13 | $260.03 |
| 83735 | <1% | 41 | $199.54 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 140 | $198.08 |
| 84484 | <1% | 96 | $177.78 | |
| 82465 | <1% | 32 | $143.81 | |
| 85014 | <1% | 13 | $97.07 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 14 | $90.63 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 145 | $84.22 |
| 85610 | <1% | 57 | $55.44 | |
| 85018 | <1% | 13 | $43.97 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 12 | $29.50 |
| 85730 | <1% | 12 | $20.31 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 65 | $1.80 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.